• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Neurogenetics  • Neurology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Jamie Lien, MD; William L. Nyhan, MD, PhD; Bruce A. Barshop, MD, PhD

Arch Neurol. 2007;64(12):1777-1779.

Background  Ornithine transcarbamylase (OTC) deficiency presents most commonly with neonatal hyperammonemic coma. The gene is on the X chromosome, but the disease may manifest as a dominant trait. Mutations that lead to later-onset presentations may lead to life-threatening disease and may be unrecognized, particularly when the first clinical disease occurs in adulthood.

Objective  To document the clinical and metabolic consequences of a mutation in the OTC gene.

Design  Case reports.

Setting  A metabolic/biochemical genetic referral service.

Main Outcome Measures  Clinical and biochemical observations in 3 generations of a family.

Results  A mutation in codon 208 of exon 6 in the OTC gene was found in a family in which the proband died of hyperammonemia at 52 years of age.

Conclusions  Diagnosis of late-onset presentations of urea cycle defect in adults may be delayed. Heightened awareness could lead to effective treatment.

Author Affiliations: Department of Pediatrics, University of California, San Diego, La Jolla.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fatal ammonia toxicity in an adult due to an undiagnosed urea cycle defect: under-recognition of ornithine transcarbamylase deficiency
Thurlow et al.
Ann Clin Biochem 2010;47:279-281.
ABSTRACT | FULL TEXT